BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[Bet on T&A with J&J (JNJ)]]>http://www.bloggingstocks.com/2008/12/01/bet-on-tanda-with-jandj-jnj/http://www.bloggingstocks.com/2008/12/01/bet-on-tanda-with-jandj-jnj/http://www.bloggingstocks.com/2008/12/01/bet-on-tanda-with-jandj-jnj/#commentsFiled under: , , , ,

Over the long holiday weekend, I had a chance to do some much needed reading. Given my vocation, sometimes I like to read articles that have little to do with the markets or finance as a way of recharging my batteries.

Of course, even when I partake in this guilty pleasure, there really is no way to truly escape. Somehow every story has a link or relationship to investing that I can utilize in my stock-picking mission.

This weekend, it was an article critical of a Shape magazine cover featuring a bikini-clad Faith Hill that has import for individual investors. In this particular article, the author does a really great job of highlighting the battle of fitness versus self-image.

How exactly did the 41-year-old country singer get that body? Was it photoshopped? How about plastic surgery? Is it really fair to present her in that way without the caveats, if any? The image alone implies that this woman, a busy professional with young children, managed to eat right and exercise in a way that created the image you now see on the magazine -- and that you can achieve yourself.

Wow, what pressure. The problem, of course, is that Photoshop was probably used in this instance, and if not Photoshop, then plastic surgery for certain.

So what does this have to do with investing?

This morning I awoke to the news that Johnson & Johnson (NYSE: JNJ) announced a definitive agreement to purchase Mentor (NYSE: MNT), a leading supplier of medical products for the global aesthetic market -- namely, breast implants.

JNJ is paying $31 per share, or $1.07 billion in cash, for the company. The purchase price is about double what MNT fetched in the open market on Friday.

A premium price of that magnitude in this market environment is hard to believe, but I would not bet against JNJ here. They have their pulse on the market and a copy of Shape magazine on their desk. As the baby-boomer generation ages, plastic surgery looks to be a huge market. Fueled by images like those in Shape magazine, the market is more than worthy of a premium price.

The fact that MNT was valued at the purchase price as recently as June is telling. Yes, the economy is in recession, but the desire to improve self image is alive and well.

This is a brilliant deal for JNJ. The company enters a strong market with great demographics at a time of economic weakness. Taking advantage of a strong balance sheet and rich cash flow, JNJ is a winner in this economy.

Self-image issues aside, I like this deal.

Jamie Dlugosch is a contributor to InvestorPlace.com.

Bet on T&A with J&J (JNJ) originally appeared on BloggingStocks on Mon, 01 Dec 2008 15:40:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>baby boomersBabyBoomersbreast implantsBreastImplantsfeaturedJNJMentorMentor CorpMentorCorpMNTplastic surgeryPlasticSurgeryMon, 01 Dec 2008 15:40:00 EST<![CDATA[Johnson & Johnson (JNJ) buying Mentor (MNT) a good sign]]>http://www.bloggingstocks.com/2008/12/01/johnson-and-johnson-jnj-buying-mentor-mnt-a-good-sign/http://www.bloggingstocks.com/2008/12/01/johnson-and-johnson-jnj-buying-mentor-mnt-a-good-sign/http://www.bloggingstocks.com/2008/12/01/johnson-and-johnson-jnj-buying-mentor-mnt-a-good-sign/#commentsFiled under: , , , , , ,

JNJ logoJohnson & Johnson (NYSE: JNJ - option chain) shares are lower today after the medical giant announced it would acquire breast implant company Mentor (NYSE: MNT). JNJ put the price for MNT at $31 per share, more than 90% above Friday's price of $16. This kind of buyout activity could signal a couple things. First JNJ is in pretty good financial shape and second that many stocks are undervalued and that resilient companies like JNJ might be looking into making moves in the coming months. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on JNJ.

JNJ opened this morning at $57.66. So far today the stock has hit a low of $56.45 and a high of $57.82. As of 12:40, JNJ is trading at $56.49, down $2.09 (3.6%). The chart for JNJ looks bullish and S&P gives JNJ its highest 5 STARS (out of 5) strong buy ranking.

For a bullish hedged play on this stock, I would consider a December bull-put credit spread below the $50 range. A bull-put credit spread is an options position that combines the purchase and sale of put options to hedge risk in case the stock doesn't do what you think but still leverage nice returns. For this particular trade, we will make a 7.5% return in just three weeks as long as JNJ is above $50 at December expiration. Johnson & Johnson would have to fall by more than 11% before we would start to lose money. Learn more about this type of trade here.

JNJ hasn't been below $52 at all in the past year and has shown support around $56 recently.

Brent Archer is an options analyst and writer at Investors Observer.

DISCLOSURE: Mr. Archer owns and/or controls diversified portfolios of long and short stock and option positions that may include holdings in companies he writes about. At publication time, Brent neither owns nor controls positions in MNT. He does control a bullish hedged position in JNJ.

Johnson & Johnson (JNJ) buying Mentor (MNT) a good sign originally appeared on BloggingStocks on Mon, 01 Dec 2008 13:35:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>breast implantsBreastImplantsinthenewsinvestors observerInvestorsObserverJNJjohnson and johnsonJohnsonAndJohnsonMentorMNToptionsMon, 01 Dec 2008 13:35:00 EST